Ledger.Open graph →
SEC Form D · Amendment · filed October 21, 2013

Lewis & Clark Pharmaceuticals, Inc

Offering
$750K
Sold
$375K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Joel Linden · Charlottesville, VADirectorLarry Rodman · Charlottesville, VAExecMiette Michie · Charlottesville, VAExecRobert Thompson · Charlottesville, VAExec · DirectorThomas Carter · Charlottesville, VADirectorRobert W. Allen · Salt Lake City, UTExec · DirectorJames R. Gillis · Salt Lake City, UTExecWilliam S. Kies, Jr · Salt Lake City, UTExecRichard K. Juliano · Salt Lake City, UTDirectorRonald C. Hodge · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗